IL1B and stroke disorder: The mechanism underlying rosuvastatin’s efficacy in stroke may be related to its ability to modulate microglial activation status, upregulate anti-inflammatory cytokines (IL-10) and suppress pro-inflammatory gene expression (IL-1β, TNF-α) [124].